dontaskme,
it's no surprise that you don't get asked considering your comment/quip
"pfft looks the same as any Ta based report..."
This was a bleeding FA based "broker opinion" based on PE in the negative.
Don't bleeding Ask FA is THE Method as used by respectables,proper investment strategists like Blessed Warren Buffett,supposedly the World's Greatest Share Market Guru.
This "Analists[sic] Report" is completely usual and typical of a Purist FA opinion in classifying a share like PEK ie no/negative earnings=AVOID.
So dontasknme can you handle that "Experts",Respectable adherents of the Status Quo are telling you that you in their learned opinion are a Dill!! who is supporting a share that THEY,the arbiters of worthwhile investing say is a DUD with negative earnings.
if you ask me don't mate They are reporting that Pek is a Dud.No doubt they recommend Molycorp over the LYC "pretender" but I haven't read these poncers opinion.
Thing is donasme, you have categorised TA with FA as "pfttt" and I'm asking what discipline of Analysis you advocate instead of either?
Of course is it "Gut Instinct" or more politely Scenario Trading ie you're swallowing/backing the Story?
The story has no "scientific" FA basis.
The story as yet has no TA basis of Established Uptrend whatsoever.
It's just a story,a scenario around the comeback of REE and a wannabe PEK who may have the goods to satisfy for fun'n'profit.
but don't ask me,it'll be basic TA that will light the Way to actual Truth of this scenario long before FA modelling based on Realo Earnings ever gets a shoo in.
As to story believing?
I always remember the words of Hector Hapeta,whoremaster/Bludger in criminal patois and his advice to the novice recruit to his enterprise
Don't swallow it!!
happy trading
- Forums
- ASX - By Stock
- analyst report
dontaskme,it's no surprise that you don't get asked considering...
Featured News
Add PEK (ASX) to my watchlist
(20min delay)
|
|||||
Last
11.0¢ |
Change
0.005(4.76%) |
Mkt cap ! $33.70M |
Open | High | Low | Value | Volume |
11.0¢ | 11.3¢ | 11.0¢ | $163.7K | 1.489M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
11 | 302441 | 10.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
11.5¢ | 344131 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
10 | 282441 | 0.105 |
18 | 1604185 | 0.100 |
2 | 389770 | 0.099 |
2 | 520408 | 0.098 |
1 | 36500 | 0.096 |
Price($) | Vol. | No. |
---|---|---|
0.115 | 344131 | 4 |
0.120 | 228000 | 3 |
0.125 | 610834 | 5 |
0.130 | 150000 | 1 |
0.135 | 71668 | 5 |
Last trade - 15.56pm 12/11/2024 (20 minute delay) ? |
Featured News
PEK (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online